Literature DB >> 12843230

MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney.

Lionel G Bouchet1, Wesley E Bolch, H Pablo Blanco, Barry W Wessels, Jeffry A Siegel, Didier A Rajon, Isabelle Clairand, George Sgouros.   

Abstract

UNLABELLED: As one of the major organs of the excretory pathway, the kidneys represent a frequent source of radiopharmaceutical uptake in both diagnostic and therapeutic nuclear medicine. The unique organization of the functional tissues of the organ ensures transient changes in suborgan localization of renal activity. Current single-region dosimetric models of the kidneys, however, force the assumption of a uniform distribution of radioactivity across the entire organ. The average absorbed dose to the kidneys predicted by such models can misrepresent local regional doses to specific substructures.
METHODS: To facilitate suborgan dosimetry for the kidneys, 6 new age-dependent multiregion kidney models are presented. The outer dimensions of the models conform to those used currently in single-region kidney models, whereas interior structures are defined for the renal cortex, the medullary pyramids with papillae (2 vertical and 3 horizontal), and the renal pelvis. Absorbed fractions of energy were calculated for both photon and electron sources (10 keV to 4 MeV) located in each source region within the 6 age-dependent models. The absorbed fractions were then used to assemble S values for radionuclides of potential interest in suborgan kidney dosimetry.
RESULTS: For the adult, the absorbed dose to the renal cortex for (90)Y-labeled compounds retained within that subregion is approximately 1.3 times that predicted by the single-region kidney model, whereas the medullary dose is only 26% of that same single-region value. For compounds that are rapidly filtered in the kidneys, the renal cortex dose is approximately one-half of that predicted under the single-region model, whereas the tissues of the medullary pyramids receive an absorbed dose 1.5-1.8 times larger.
CONCLUSION: The multiregion model described here permits estimates of regional kidney dose not previously supported by current single-region models. Full utilization of the new model, however, requires serial imaging of the kidneys with regions of interest assigned to the renal cortex and medulla.

Mesh:

Substances:

Year:  2003        PMID: 12843230

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  35 in total

1.  Human radiation dosimetry of [11C]MeAIB, a new tracer for imaging of system A amino acid transport.

Authors:  Tuula Tolvanen; Kjell Någren; Meixiang Yu; Eija Sutinen; Katja Havu-Aurén; Sirkku Jyrkkiö; Markku Asola; Eira Kotoneva; Pirjo Nuutila; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-24       Impact factor: 9.236

Review 2.  Challenges and progress in predicting biological responses to incorporated radioactivity.

Authors:  R W Howell; P V S V Neti; M Pinto; B I Gerashchenko; V R Narra; E I Azzam
Journal:  Radiat Prot Dosimetry       Date:  2007-02-06       Impact factor: 0.972

3.  Calculation of electron dose to target cells in a complex environment by Monte Carlo code "CELLDOSE".

Authors:  Elif Hindié; Christophe Champion; Paolo Zanotti-Fregonara; Domenico Rubello; Nicole Colas-Linhart; Laura Ravasi; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

4.  Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody.

Authors:  J Schwartz; J S Jaggi; J A O'Donoghue; S Ruan; M McDevitt; S M Larson; D A Scheinberg; J L Humm
Journal:  Phys Med Biol       Date:  2011-01-10       Impact factor: 3.609

5.  Assessment of MIRD data for internal dosimetry using the GATE Monte Carlo code.

Authors:  Ali Asghar Parach; Hossein Rajabi; Mohammad Ali Askari
Journal:  Radiat Environ Biophys       Date:  2011-05-15       Impact factor: 1.925

6.  Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible.

Authors:  Ram Kumar Selvaraju; Thomas N Bulenga; Daniel Espes; Mark Lubberink; Jens Sörensen; Barbro Eriksson; Sergio Estrada; Irina Velikyan; Olof Eriksson
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-02-15

7.  Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy.

Authors:  Irina Velikyan; Thomas N Bulenga; Ramkumar Selvaraju; Mark Lubberink; Daniel Espes; Ulrika Rosenström; Olof Eriksson
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

Review 8.  An exponential growth of computational phantom research in radiation protection, imaging, and radiotherapy: a review of the fifty-year history.

Authors:  X George Xu
Journal:  Phys Med Biol       Date:  2014-08-21       Impact factor: 3.609

Review 9.  Modelling and dosimetry for alpha-particle therapy.

Authors:  George Sgouros; Robert F Hobbs; Hong Song
Journal:  Curr Radiopharm       Date:  2011-07

10.  Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

Authors:  Arnaud Dieudonné; Robert F Hobbs; Rachida Lebtahi; Fabien Maurel; Sébastien Baechler; Richard L Wahl; Ariane Boubaker; Dominique Le Guludec; Georges Sgouros; Isabelle Gardin
Journal:  J Nucl Med       Date:  2012-12-18       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.